Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-512192-12-00Phase 4Authorised
Phase 4 trial of prednisolone in Acute Laryngitis, sponsored by Helsinki University Hospital. Primary endpoint: Duration of vocal symptoms. Planned start Oct 2024; status: authorised.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-512192-12-00.